Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Müller-Spahn

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Annals of the New York Academy of Sciences|January 17, 1996
Near infrared spectroscopy in the diagnosis of Alzheimer's diseaseC Hock, K Villringer, F Müller-Spahn, et al.
Schizophrenia Bulletin|March 21, 1998
Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorderS Doering, E Müller, W Köpcke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Increased blood mercury levels in patients with Alzheimer's diseaseC Hock, G Drasch, S Golombowski, et al.
Fortschritte Der Neurologie-Psychiatrie|January 1, 1986
[Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables]M Albus, D Naber, M Ackenheil, et al.
Brain Research|May 2, 1997
Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurementsC Hock, K Villringer, F Müller-Spahn, et al.
Neurobiology of Aging|December 21, 2002
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degenerationS J Teipel, W Bayer, G E Alexander, et al.
European Neurology|March 31, 1998
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severityC Hock, S Golombowski, F Müller-Spahn, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Annals of the New York Academy of Sciences|January 17, 1996
Near infrared spectroscopy in the diagnosis of Alzheimer's diseaseC Hock, K Villringer, F Müller-Spahn, et al.
Schizophrenia Bulletin|March 21, 1998
Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorderS Doering, E Müller, W Köpcke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Increased blood mercury levels in patients with Alzheimer's diseaseC Hock, G Drasch, S Golombowski, et al.
Fortschritte Der Neurologie-Psychiatrie|January 1, 1986
[Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables]M Albus, D Naber, M Ackenheil, et al.
Brain Research|May 2, 1997
Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurementsC Hock, K Villringer, F Müller-Spahn, et al.
Neurobiology of Aging|December 21, 2002
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degenerationS J Teipel, W Bayer, G E Alexander, et al.
European Neurology|March 31, 1998
Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severityC Hock, S Golombowski, F Müller-Spahn, et al.
Pageof 10